FocusPolicy

Evolution in translational science: Whither the CTSAs?

See allHide authors and affiliations

Science Translational Medicine  22 Apr 2015:
Vol. 7, Issue 284, pp. 284fs15
DOI: 10.1126/scitranslmed.aab1596

Figures

  • Early-career scientists face a future of human phenotyping.

    CTRCs provide substantial support to young clinical and translational investigators. To frame this in fiscal terms alone, the Penn-CHOP integrated CTRC provided subsidies to investigators pursuing NIH-supported research—roughly half of whom are assistant professors—worth $5,325,648 in FY2010, dropping to $3,945,287 in FY2013 as charge-back fees to investigators were gradually introduced.

    CREDIT: TIM FLACH/GETTY

Stay Connected to Science Translational Medicine

Navigate This Article